Ovarian cancer and fallopian tube cancer Radiotherapy

Radiotherapy is a type of cancer treatment in which high-energy X-rays are used to kill cancer cells.

Radiotherapy is carried out as an outpatient treatment, does not require anesthesia and can be easily integrated into everyday private and professional life. The treatments are not painful and each radiation session only takes a few minutes.

Each patient is discussed in detail by a panel of experts from all relevant specialist areas. After this discussion, the patient is presented with the optimal choice of treatment and her wishes and opinion are taken into account. Personal support is a matter of course for us.

The Department of Radiation Oncology at the USZ uses only the most modern techniques for precise radiotherapy of ovarian or fallopian tube cancer with few side effects. State-of-the-art equipment and experienced medical staff contribute to treatment of optimum quality and safety.

You will be looked after by internationally recognized experts in the research and treatment of gynaecological cancer. The irradiation of gynecological cancer with a modern magnetic resonance guided technique is a clinical and scientific focus of Prof. P. Petric. He passes on his knowledge in a variety of international courses and congresses.

Our team works closely with our colleagues in gynecology and medical oncology in order to guarantee “one-stop” treatment.

In clinical trials, we are continuously working on improving the treatment of ovarian cancer and fallopian tube cancer to make it even more effective and tolerable. To the overview of currently open studies.

In the following, we will describe radiotherapy for the different types and stages of ovarian cancer and fallopian tube cancer.

Postoperative radiotherapy

Post-operative radiotherapy is very rarely used for ovarian cancer or fallopian tube cancer. It is sometimes recommended in carefully selected cases after surgery to kill any cancer cells that may have remained.

Metastases of ovarian cancer and fallopian tube cancer, e.g. in the brain or bones

Ovarian cancer and fallopian tube cancer are aggressive types of cancer that often form metastases during the course of the disease: this is called metastasis. Common sites of metastasis are the lung, adrenal gland, bones, liver or brain. Radiotherapy is a highly effective method with few side effects to prevent or treat symptoms caused by metastases. This is usually done in combination with chemotherapy, immunotherapy or other targeted therapy. The smaller the metastases are and the earlier they are irradiated, the better the results. Today, metastases in the body can be treated in a focused manner in just a few effective radiation sessions.

For tumor foci in the abdominal area, e.g. liver or upper abdomen, we carry out body stereotactic radiotherapy (SBRT) on our MRI hybrid accelerator. State-of-the-art radiation technology is combined with MRI images. The radiation is thus carried out under MRI monitoring of the tumor, so that the highest precision is combined with the best imaging. Our clinic was the first in Switzerland to introduce this technology back in 2019. We are still the only clinic in German-speaking Switzerland to offer the highest level of expertise in this field.

Today, brain metastases are treated at our center in most patients by means of a single high-dose radiation treatment: this is called radiosurgery.

Metastases at other locations in the body can now also be treated in a focused manner in just a few effective radiation sessions. Metastatic cancers are a clinical and scientific focus of our clinic. We pass on our knowledge in a large number of international courses and congresses. We are active as international experts in guideline commissions.

State-of-the-art equipment and experienced medical physicists and MTRAs contribute to treatment of optimum quality and safety. At the same time, we work closely with our colleagues in medical oncology to guarantee “one-stop” treatment. We also consult with our colleagues in palliative medicine at an early stage.

In clinical trials, we are continuously trying to improve the treatment of ovarian cancer and fallopian tube cancer in order to make it even more effective and tolerable. To the overview of currently open studies.

  • Characterization and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Guckenberger M, Lancet Oncol. 2020(1):e18-e28.
  • Article in FrenchRational combinations of immunotherapy with radiotherapy in ovarian cancer. Herrera F et al Lancet Oncol 2019
  • Stereotactic body radiation therapy in the treatment of ovarian cancer. Kowalchuk, R.O.

Responsible professionals

Claudia Linsenmeier, Dr. med.

Senior Attending Physician, Department of Radiation Oncology

Tel. +41 44 255 26 73
Specialties: Focus on breast/gynecology, Gastro-Intestinal Radio-Oncology, Pediatric radio-oncology

For patients

As a patient, you cannot register directly for a consultation. Please get a referral from your primary care physician, specialist.

Contact form

For referrering physicians

Simply assign your patient online or by email.

Tel. +41 44 255 35 66
Patient registration form

Responsible Department

Related diseases